Fulgent Genetics
Fulgent Q3 Total Revenues Fall 54 Percent, Non-COVID Revenues Double
Separately, Fulgent Genetics also announced that it will acquire Fulgent Pharma for $100 million.
360Dx Top 30 Tumbles in August
Of the 30 diagnostic companies in the index, 22 saw their share prices decline, while eight firms saw stock prices rise.
Fulgent Genetics Q2 Revenues Fall 18 Percent on Declining COVID Business
The firm touted a doubling of its core non-COVID business despite challenging macroeconomic headwinds.
Inform Diagnostics to Pay $16M to Settle False Claims Allegations
Company officials performed additional tests on biopsy specimens without orders from physicians or pathologists, according to the US Department of Justice
In Brief This Week: Thermo Fisher Scientific, FDA, Fulgent Genetics, OpGen, More
News items for the week of July 4, 2022.
Apr 21, 2022
Jan 4, 2022
360Dx Index Rises 20 Percent in 2021
Aug 10, 2021
Mar 4, 2021